K

Vitamin K is an essential vitamin that plays a crucial role in various bodily functions, particularly in blood clotting and bone health. It is a fat-soluble vitamin, meaning it dissolves in fats and oils and can be stored in the body's fatty tissue.



What is Vitamin K?

Vitamin K is an essential vitamin that plays a crucial role in various bodily functions, particularly in blood clotting and bone health. It is a fat-soluble vitamin, meaning it dissolves in fats and oils and can be stored in the body's fatty tissue. There are two primary forms of Vitamin K: Vitamin K1 (phylloquinone) and Vitamin K2 (menaquinone). Vitamin K1 is predominantly found in green leafy vegetables and is primarily involved in maintaining blood clotting. On the other hand, Vitamin K2 is found in fermented foods and animal products and has additional roles in bone and cardiovascular health.

Vitamin K is integral to the body's ability to produce prothrombin, a protein and clotting factor that is critical in blood coagulation. Without adequate Vitamin K, the blood's ability to clot properly is impaired, which can lead to excessive bleeding. This is why Vitamin K is often administered to newborns, who are naturally deficient in this vitamin, to prevent bleeding disorders.

In addition to its role in blood clotting, Vitamin K has garnered attention for its benefits in bone health. It activates proteins that regulate bone formation and bone mineralization, helping to maintain strong and healthy bones. Some studies suggest that Vitamin K2, in particular, may help reduce the risk of bone fractures and support overall bone density, making it a vital nutrient for maintaining skeletal health, especially in older adults.

In summary, Vitamin K is a vital nutrient essential for blood clotting and bone health, available in two primary forms, K1 and K2, each with distinct sources and roles in the body.

Back to table of contents


What is Vitamin K used for, and what do the studies say?

Vitamin K is used primarily for its essential role in blood clotting and bone health, but emerging research has illuminated a variety of other potential benefits and applications.

In the realm of blood clotting, Vitamin K is indispensable. It activates a group of proteins called clotting factors, which are necessary for the blood to coagulate and stop bleeding. This is why Vitamin K is often administered to newborns to prevent hemorrhagic disease, a condition caused by Vitamin K deficiency that can lead to severe bleeding in infants. In adults, Vitamin K is also crucial for preventing excessive bleeding after injuries or surgeries.

Vitamin K's role in bone health is another key application. Studies have shown that Vitamin K2, in particular, is effective in activating osteocalcin, a protein that binds calcium to bones, thereby increasing bone mineral density. A meta-analysis published in "Osteoporosis International" found that Vitamin K supplementation could help reduce the rate of bone loss in postmenopausal women, although the evidence is not uniformly conclusive across all studies (Mott et al., 2019). Another study in the "Journal of Orthopaedic Surgery and Research" indicated that Vitamin K, when combined with calcium, significantly improved lumbar spine bone mineral density (Hu et al., 2021).

Beyond these well-established uses, Vitamin K is being investigated for its potential in reducing the risk of certain cancers. Some research suggests that high dietary intake of menaquinones (Vitamin K2) may be associated with a reduced risk of cancer incidence and mortality. For instance, a study in "The American Journal of Clinical Nutrition" found that a higher intake of Vitamin K2 was linked to a lower risk of overall cancer incidence and mortality (Nimptsch et al., 2010). However, it is essential to note that these findings are preliminary, and more research is needed to confirm these benefits.

In summary, Vitamin K is primarily used for blood clotting and bone health, with emerging research suggesting potential roles in cancer prevention. While studies support its benefits in these areas, more research is necessary to fully understand its broader health implications.

Back to table of contents


How does Vitamin K work?

Vitamin K operates through several intricate mechanisms to fulfill its roles in blood clotting, bone health, and possibly other physiological processes. Its primary function lies in its ability to act as a cofactor for the enzyme gamma-glutamyl carboxylase, which is essential for the activation of various proteins involved in blood coagulation, bone metabolism, and cardiovascular health.

In the context of blood clotting, Vitamin K is essential for the synthesis of clotting factors II (prothrombin), VII, IX, and X, as well as proteins C and S, which are anticoagulants. These proteins require gamma-carboxylation, a process that modifies glutamic acid residues to gamma-carboxyglutamic acid (Gla). This modification allows the proteins to bind calcium ions, which is crucial for their biological activity in clot formation. Without adequate Vitamin K, these clotting factors remain inactive, leading to impaired blood coagulation and an increased risk of bleeding.

When it comes to bone health, Vitamin K plays a pivotal role by activating osteocalcin, a protein produced by osteoblasts (bone-forming cells). Osteocalcin requires gamma-carboxylation to bind calcium effectively and incorporate it into the bone matrix. Studies, such as those published in the "Journal of Orthopaedic Surgery and Research," have shown that Vitamin K2 supplementation can improve bone mineral density by enhancing the carboxylation of osteocalcin (Hu et al., 2021). This process helps maintain bone strength and reduces the risk of fractures, particularly in populations at risk for osteoporosis.

Vitamin K is also implicated in cardiovascular health through its influence on matrix Gla protein (MGP), which inhibits vascular calcification. MGP requires Vitamin K-dependent carboxylation to become active and prevent calcium deposition in the blood vessels. This action helps maintain vascular elasticity and reduces the risk of arterial stiffness and cardiovascular diseases.

In summary, Vitamin K works by activating several key proteins through gamma-carboxylation, which is essential for blood clotting, bone health, and cardiovascular protection. Its role as a cofactor in these biochemical processes underscores its importance in maintaining overall health and preventing various disorders.

Back to table of contents


How is Vitamin K used differently in men’s and women’s health?

Vitamin K plays critical roles in both men’s and women’s health, but its applications and benefits can differ slightly based on gender-specific health concerns and physiological differences.

In women's health, Vitamin K is particularly significant for bone health, especially post-menopause. As women age, they are more susceptible to osteoporosis due to hormonal changes that accelerate bone loss. Studies have shown that Vitamin K2 can help maintain bone mineral density and reduce the risk of fractures in postmenopausal women. For instance, research published in the "Journal of Korean Medical Science" demonstrated that adding Vitamin K2 to supplements of Vitamin D and calcium significantly increased bone mineral density in postmenopausal Korean women over 60 (Je et al., 2011). This makes Vitamin K2 a valuable nutrient for women looking to preserve bone health and reduce osteoporosis risk.

Moreover, some research has suggested that Vitamin K intake might have implications for breast cancer risk. A study in "Clinical Nutrition" found that dietary intake of menaquinones (Vitamin K2) could influence breast cancer incidence and mortality, although the results were not entirely conclusive (Wang et al., 2020). The potential role of Vitamin K in preventing specific cancers further underscores its importance in women's health.

In men’s health, Vitamin K also contributes to bone health, but it might play a more prominent role in cardiovascular protection. Men generally have a higher risk of developing cardiovascular diseases compared to women, and Vitamin K2 has been shown to inhibit vascular calcification, a major risk factor for heart disease. A study published in the "Journal of Epidemiology" found that higher Vitamin K intake was associated with a reduced risk of lung cancer, with stronger effects observed in men (Yan et al., 2022). This suggests that Vitamin K intake may provide additional cancer-protective benefits for men.

Additionally, while both genders can benefit from Vitamin K's role in blood clotting, men might not experience the same level of bone density benefits as women do, especially during the postmenopausal phase for women. However, ensuring adequate Vitamin K intake is still crucial for overall bone health and preventing fractures in men, particularly as they age.

In summary, Vitamin K is essential for both men’s and women’s health, with specific benefits tailored to gender-specific health concerns. In women, it is particularly valuable for maintaining bone health and potentially reducing the risk of breast cancer. In men, Vitamin K offers significant cardiovascular protection and may reduce the risk of certain cancers.

Back to table of contents


How much Vitamin K should I take?

The recommended intake of Vitamin K varies based on age, gender, and specific health needs. Generally, the Recommended Dietary Allowance (RDA) for Vitamin K differs between men and women and increases with age. According to guidelines from the National Institutes of Health (NIH), adult men should aim for about 120 micrograms (mcg) per day, while adult women should aim for about 90 mcg per day. These recommendations are designed to meet the nutritional needs of the majority of the population and ensure adequate blood clotting and bone health.

For older adults, particularly those at risk for osteoporosis, higher intakes of Vitamin K2 might be beneficial. Some studies suggest that doses of Vitamin K2 ranging from 45 to 180 micrograms per day can improve bone mineral density and reduce the risk of fractures. For example, a study in "Osteoporosis International" indicated that Vitamin K2 supplementation could help mitigate bone loss in postmenopausal women (Mott et al., 2019). However, it's important to consult with a healthcare provider before significantly increasing Vitamin K intake, especially if you are on medications that might interact with it, such as anticoagulants.

For individuals with specific health conditions or those looking to obtain the potential cardiovascular benefits of Vitamin K2, some research suggests that higher doses may be effective. For instance, doses of Vitamin K2 (menaquinone-7) around 180 micrograms per day have been used in studies to improve arterial health and reduce vascular calcification, particularly in older adults. Again, medical supervision is advised to tailor the dosage to individual health needs and conditions.

It’s also important to note that Vitamin K is fat-soluble, meaning it is stored in the body's fat tissues and liver. Therefore, maintaining a balanced intake over time is more critical than sporadic large doses. Including a variety of Vitamin K-rich foods in your diet, such as leafy green vegetables for Vitamin K1 and fermented foods or animal products for Vitamin K2, can help you meet your daily requirements.

In summary, the general daily recommended intake for Vitamin K is 120 mcg for men and 90 mcg for women, with potential benefits from higher doses of Vitamin K2 in specific populations. Consulting a healthcare provider is crucial to determine the appropriate dosage based on individual health needs and conditions.

Back to table of contents


What are the main side effects of Vitamin K?

Vitamin K is generally well-tolerated, and side effects are rare when taken at recommended doses. However, like any nutrient or supplement, it can cause adverse effects in certain situations, particularly when consumed in large amounts or when interacting with specific medications.

One of the most well-known side effects of Vitamin K, particularly in high doses, is its potential to counteract the effects of blood-thinning medications such as warfarin. Warfarin works by inhibiting Vitamin K's ability to activate clotting factors, thus preventing blood clots. If someone taking warfarin consumes large amounts of Vitamin K, it can reduce the medication's effectiveness and increase the risk of clot formation. This interaction underscores the importance of maintaining consistent Vitamin K intake if you are on anticoagulant therapy and consulting with a healthcare provider before making any changes to your diet or supplement regimen.

In rare cases, high doses of Vitamin K1 (phylloquinone) can cause allergic reactions, including skin rashes, itching, and anaphylaxis—a severe, potentially life-threatening allergic reaction. These reactions are uncommon but can occur, particularly if Vitamin K is administered via injection rather than orally.

There have also been some reports of gastrointestinal discomfort, such as nausea or diarrhea, with high doses of Vitamin K2 (menaquinone). These side effects are typically mild and resolve on their own once the dose is adjusted or discontinued.

Another consideration is the form of Vitamin K being taken. Synthetic forms of Vitamin K, such as menadione (Vitamin K3), are not recommended for human consumption due to their potential toxicity. Menadione has been shown to cause liver damage and oxidative stress in animal studies and is generally avoided in dietary supplements.

In summary, while Vitamin K is generally safe and well-tolerated, potential side effects include interaction with blood-thinning medications, rare allergic reactions, and mild gastrointestinal discomfort at high doses. It is crucial to consult with a healthcare provider to ensure safe and appropriate use, particularly if you have underlying health conditions or are taking other medications.

Back to table of contents


Who should not take Vitamin K?

While Vitamin K is essential for health, certain individuals should exercise caution or avoid supplementation unless under medical supervision. One of the primary groups that need to be careful with Vitamin K intake includes those on anticoagulant medications, such as warfarin. Warfarin works by inhibiting the action of Vitamin K, thereby preventing the formation of blood clots. Consuming large amounts of Vitamin K can counteract the effects of warfarin, leading to a risk of clot formation. Therefore, individuals on warfarin should maintain a consistent intake of Vitamin K and consult with their healthcare provider before making any significant dietary changes or starting supplements.

People with certain medical conditions might also need to avoid Vitamin K supplements. For instance, individuals with liver disease or impaired bile production may have difficulties absorbing fat-soluble vitamins, including Vitamin K. In such cases, supplementation might need to be carefully monitored by a healthcare provider to avoid potential complications or ensure proper absorption.

Those with a known allergy to Vitamin K or any of its components should avoid supplementation. Allergic reactions to Vitamin K, although rare, can include symptoms such as rash, itching, swelling, dizziness, and difficulty breathing. If any allergic symptoms occur, it is crucial to seek medical attention immediately.

Infants, particularly newborns, are often given a Vitamin K injection at birth to prevent Vitamin K deficiency bleeding. However, routine supplementation beyond this initial dose should be done under pediatric supervision. High doses of Vitamin K can be harmful to infants, so it is important to follow medical advice carefully.

Additionally, individuals with specific genetic conditions that affect Vitamin K metabolism, such as certain clotting disorders, should consult with a healthcare provider before taking Vitamin K supplements. These conditions might require specialized management and dosing that only a healthcare professional can provide.

In summary, while Vitamin K is essential, individuals on anticoagulant medications, those with liver disease, people with known allergies to Vitamin K, infants, and those with certain genetic conditions should avoid supplementation or use it only under strict medical supervision. Consulting a healthcare provider is essential to determine the appropriate use and dosage based on individual health needs and conditions.

Back to table of contents


Are Vitamin K supplements known to interact with any medications?

Yes, Vitamin K supplements are known to interact with several medications, which can affect their efficacy and safety. Understanding these interactions is crucial for anyone considering Vitamin K supplementation, especially those on specific drug regimens.

The most well-documented interaction is with anticoagulant medications, such as warfarin (Coumadin). Warfarin works by inhibiting the action of Vitamin K, thereby preventing the formation of blood clots. Vitamin K supplementation, especially in high doses, can counteract the effects of warfarin, making the medication less effective and increasing the risk of clot formation. This interaction underscores the importance of maintaining a consistent intake of Vitamin K if you are on warfarin and consulting with your healthcare provider before making any changes to your diet or supplement regimen. Regular monitoring of blood clotting times (INR tests) is often necessary to adjust the warfarin dosage appropriately.

Vitamin K can also interact with certain antibiotics, particularly broad-spectrum antibiotics. These medications can reduce the levels of Vitamin K-producing bacteria in the gut, potentially leading to a deficiency. While this interaction generally affects Vitamin K1, it can also influence the overall balance of Vitamin K in the body. If you're on a long-term antibiotic regimen, your healthcare provider may recommend monitoring your Vitamin K status and adjusting your intake as needed.

Another potential interaction involves bile acid sequestrants, such as cholestyramine and colestipol, used to lower cholesterol levels. These medications can interfere with the absorption of fat-soluble vitamins, including Vitamin K. This can lead to decreased Vitamin K levels in the body, increasing the risk of bleeding. If you're taking bile acid sequestrants, your healthcare provider may suggest Vitamin K supplementation or alternative lipid-lowering therapies.

Certain anticonvulsant medications, such as phenytoin and phenobarbital, can also affect Vitamin K levels. These drugs can interfere with the metabolism of Vitamin K, potentially leading to deficiency. Monitoring and possibly supplementing with Vitamin K may be necessary for individuals on long-term anticonvulsant therapy.

Lastly, high doses of Vitamin E supplements can interfere with Vitamin K's role in blood clotting. Vitamin E can inhibit Vitamin K-dependent carboxylation of clotting factors, increasing the risk of bleeding. If you are taking both Vitamin E and Vitamin K supplements, it is essential to consult your healthcare provider to ensure balanced and safe dosages.

In summary, Vitamin K supplements can interact with anticoagulants, certain antibiotics, bile acid sequestrants, anticonvulsants, and high doses of Vitamin E. It is crucial to consult with a healthcare provider to manage these interactions effectively and ensure safe supplementation.

Back to table of contents


What are the best sources of Vitamin K?

Vitamin K is available from a variety of dietary sources, making it relatively easy to include in a balanced diet. The vitamin exists in two primary forms, Vitamin K1 (phylloquinone) and Vitamin K2 (menaquinone), each found in different types of foods.

Vitamin K1 is predominantly found in green leafy vegetables. Some of the best sources include kale, spinach, broccoli, Brussels sprouts, and collard greens. These vegetables are not only rich in Vitamin K1 but also packed with other essential nutrients, making them excellent choices for overall health. For instance, a single cup of cooked kale can provide more than 500 micrograms of Vitamin K1, well above the recommended daily intake.

Vitamin K2 is found in fermented foods and certain animal products. Natto, a traditional Japanese fermented soybean dish, is one of the richest sources of Vitamin K2, specifically menaquinone-7 (MK-7). Other fermented foods like sauerkraut, kimchi, and certain cheeses (especially hard cheeses like Gouda and Jarlsberg) also provide significant amounts of Vitamin K2. Animal products such as liver, egg yolks, and meat, particularly from grass-fed animals, contain menaquinone-4 (MK-4), another form of Vitamin K2.

In addition to these natural food sources, some fortified foods can help boost Vitamin K intake. Certain brands of dairy products, cereals, and plant-based milk alternatives may be fortified with Vitamin K. Always check the nutrition labels to identify these fortified options.

For those who may struggle to get enough Vitamin K from their diet, particularly individuals with dietary restrictions or specific health conditions, supplements can be an effective option. Vitamin K supplements are available in various forms, including pills, capsules, and liquid drops. These supplements typically contain either Vitamin K1, Vitamin K2 (as MK-4 or MK-7), or a combination of both. It's important to choose high-quality supplements and consult with a healthcare provider to determine the appropriate dosage and form based on individual health needs.

In summary, the best sources of Vitamin K1 are green leafy vegetables such as kale and spinach, while Vitamin K2 is abundant in fermented foods like natto and certain cheeses, as well as in animal products like liver and egg yolks. Incorporating a variety of these foods into your diet can help ensure adequate intake of this essential nutrient.

Back to table of contents


What forms does Vitamin K come in?

Vitamin K comes in several forms, each with distinct sources and roles in the body. The primary forms are Vitamin K1 (phylloquinone) and Vitamin K2 (menaquinone), but there are also synthetic forms and lesser-known variants that play unique roles in health.

Vitamin K1 (Phylloquinone): Vitamin K1 is the most common form found in the diet and is primarily sourced from green leafy vegetables such as kale, spinach, broccoli, Brussels sprouts, and collard greens. It plays a vital role in blood clotting by aiding the synthesis of clotting factors in the liver. Because it is fat-soluble, it is best absorbed when consumed with dietary fats. Phylloquinone is also available in supplement form, typically as tablets or capsules, for those who may need additional intake beyond dietary sources.

Vitamin K2 (Menaquinone): Vitamin K2 exists in several subtypes, known as menaquinones, which are denoted by MK-n, where "n" represents the number of isoprenoid side chain units. The most studied and significant subtypes are MK-4 and MK-7.

  • MK-4: This subtype of Vitamin K2 is found in small amounts in animal products such as meat, liver, and egg yolks. It is synthesized by animal tissues and plays a crucial role in bone health by activating proteins that regulate bone mineralization. MK-4 has a shorter half-life in the body compared to other menaquinones, which means it needs to be consumed more frequently.
  • MK-7: MK-7 is abundant in fermented foods, particularly natto, a traditional Japanese dish made from fermented soybeans. It has a longer half-life, allowing it to stay active in the body for a longer period, which may provide more sustained benefits for bone and cardiovascular health. MK-7 is also available as a dietary supplement, often marketed for its bone health benefits.

Synthetic Forms:

  • Vitamin K3 (Menadione): This is a synthetic form of Vitamin K and is not commonly used in human supplements due to potential toxicity. Menadione can interfere with the body's natural antioxidant mechanisms and has been linked to liver toxicity and oxidative stress in animal studies.

Other Forms:

  • MK-8 and MK-9: These are other subtypes of menaquinone found in certain fermented foods and cheeses. While less commonly studied than MK-4 and MK-7, they also contribute to Vitamin K2's overall health benefits.

Supplement Forms: Vitamin K supplements are available in various forms, including tablets, capsules, and liquid drops. They may contain Vitamin K1, Vitamin K2 (as MK-4 or MK-7), or a combination of both. When choosing a supplement, it’s essential to consider the specific health benefits associated with each form and consult with a healthcare provider to determine the appropriate type and dosage.

In summary, Vitamin K comes in several forms, primarily Vitamin K1 (phylloquinone) and Vitamin K2 (menaquinone), with the latter including subtypes like MK-4 and MK-7. Each form has unique sources, functions, and health benefits, making it important to choose the right type based on individual health needs.

Back to table of contents


Which sub-compounds of Vitamin K, if any, are critical to the efficacy of Vitamin K?

The efficacy of Vitamin K is significantly influenced by its sub-compounds, particularly Vitamin K1 (phylloquinone) and various forms of Vitamin K2 (menaquinones), with MK-4 and MK-7 being the most critical. Each of these sub-compounds plays unique roles in the body and offers distinct health benefits.

Vitamin K1 (Phylloquinone): Vitamin K1 is primarily responsible for the activation of clotting factors, which are essential for blood coagulation. Its efficacy is paramount in preventing excessive bleeding and ensuring proper wound healing. Phylloquinone is efficiently utilized by the liver to synthesize clotting factors such as prothrombin, which is crucial for the blood clotting process. This form of Vitamin K is abundant in green leafy vegetables, making it readily accessible through a balanced diet.

Vitamin K2 (Menaquinones): Vitamin K2 is a group of compounds known as menaquinones, which differ in their side chain length. The most studied and critical menaquinones are MK-4 and MK-7, each offering unique benefits beyond blood clotting.

  • MK-4 (Menaquinone-4): MK-4 is found in animal products such as meat, liver, and egg yolks. It plays a crucial role in bone health by activating osteocalcin, a protein that binds calcium to the bone matrix, enhancing bone mineralization and strength. MK-4 also activates matrix Gla protein (MGP), which helps prevent calcium deposits in the arteries, thus contributing to cardiovascular health. Although MK-4 has a shorter half-life in the body, it is directly utilized by tissues like bones and blood vessels, making it effective for targeted health benefits.
  • MK-7 (Menaquinone-7): MK-7 is abundant in fermented foods like natto and certain cheeses. It has a longer half-life compared to MK-4, allowing it to stay active in the body for a more extended period. This extended activity makes MK-7 particularly effective in maintaining consistent levels of activated osteocalcin and MGP, providing sustained benefits for bone and cardiovascular health. Studies have shown that MK-7 supplementation can significantly improve bone mineral density and reduce arterial stiffness, making it a valuable form of Vitamin K2 for long-term health benefits (Kuang et al., 2020).

Other Menaquinones (MK-8, MK-9, etc.): While MK-4 and MK-7 are the most researched and critical to Vitamin K efficacy, other menaquinones like MK-8 and MK-9 also contribute to overall health. These sub-compounds are found in fermented foods and cheeses and participate in similar biochemical pathways, although their specific roles and benefits are less well-defined.

Role in Carboxylation: The primary mechanism through which these sub-compounds of Vitamin K exert their effects is by serving as cofactors for the enzyme gamma-glutamyl carboxylase. This enzyme catalyzes the carboxylation of specific glutamate residues on proteins, transforming them into gamma-carboxyglutamate (Gla) residues. This modification is essential for the biological activity of several proteins involved in blood clotting, bone metabolism, and cardiovascular health. The ability of Vitamin K sub-compounds to support this carboxylation process underpins their efficacy in various physiological functions.

In summary, the critical sub-compounds of Vitamin K that contribute to its efficacy are Vitamin K1 (phylloquinone), MK-4, and MK-7. Each of these forms plays unique and essential roles in blood clotting, bone health, and cardiovascular protection, making them vital components of a comprehensive approach to health.

Back to table of contents


What is Vitamin K also known as?

Vitamin K is known by several names, abbreviations, and chemical compounds, reflecting its different forms and functions. Here is a comprehensive list of what Vitamin K is also known as, including common misspellings and related terms:

  1. Phylloquinone: This is another name for Vitamin K1. It is the most common form of Vitamin K found in green leafy vegetables. It can sometimes be misspelled as "phyloquinone" or "phylloquinine."
  2. Menaquinone: This is the general term for Vitamin K2 and includes several subtypes known by their specific chain lengths, such as MK-4, MK-7, MK-8, and MK-9. Common misspellings include "menaquinon" or "menaquinine."
  3. Menatetrenone: This is another name for MK-4, a subtype of Vitamin K2. It is sometimes referred to in scientific literature and supplements.
  4. Naphthoquinone: This term refers to the chemical structure shared by all Vitamin K forms. It is sometimes used in the context of the vitamin's biochemical properties.
  5. Koagulation Vitamin: The original name given to Vitamin K when it was discovered, reflecting its essential role in blood coagulation.
  6. Vitamin K1: Often used to refer specifically to phylloquinone, the plant-based form of Vitamin K.
  7. Vitamin K2: Refers to the menaquinone series, which includes several subtypes such as MK-4 and MK-7. It can sometimes be abbreviated as "Vit K2."
  8. MK-4: A subtype of Vitamin K2, also known as menatetrenone. It is found in animal products and synthesized by tissues in the body.
  9. MK-7: Another subtype of Vitamin K2, abundant in fermented foods like natto. It is known for its longer half-life and sustained activity in the body.
  10. Menadione: This is a synthetic form of Vitamin K, also known as Vitamin K3. It is not commonly used in human supplements due to potential toxicity but may appear in animal feed.
  11. K Vitamins: A collective term for all forms of Vitamin K, including K1, K2, and synthetic forms.
  12. Vit K: A common abbreviation for Vitamin K, used in both medical and nutritional contexts.
  13. Phytonadione: This is the pharmaceutical form of Vitamin K1, often used in supplements and injections to treat deficiencies.

In summary, Vitamin K is also known as phylloquinone (Vitamin K1), menaquinone (Vitamin K2), menatetrenone (MK-4), naphthoquinone, koagulation vitamin, and menadione (Vitamin K3). Common abbreviations include Vit K, Vitamin K1, and Vitamin K2. Understanding these various names and terms can help in identifying the different forms and sources of Vitamin K in dietary supplements and scientific literature.

Back to table of contents


What is important to look for on the label of a Vitamin K supplement to ensure product quality?

When selecting a Vitamin K supplement, it is essential to scrutinize the label to ensure product quality and efficacy. Here are some key factors to consider:

  1. Type of Vitamin K: Identify the specific form of Vitamin K in the supplement. It should clearly state whether it contains Vitamin K1 (phylloquinone) or Vitamin K2 (menaquinone), and if it's Vitamin K2, the subtype (MK-4, MK-7, etc.) should be specified. Each form has different benefits, so choose one that aligns with your health goals.
  2. Dosage: Check the amount of Vitamin K per serving. The label should specify the dosage in micrograms (mcg) or milligrams (mg). Compare this with the Recommended Dietary Allowance (RDA) and your specific needs, which may vary based on age, gender, and health conditions.
  3. Purity and Additives: Look for a supplement that has minimal additives, fillers, or artificial ingredients. The fewer the additives, the purer the product. Avoid supplements with unnecessary colorings, preservatives, or synthetic ingredients that might cause adverse reactions.
  4. Source and Form: Ensure that the supplement uses a high-quality source of Vitamin K. For instance, MK-7 is often derived from natto (fermented soybeans) and is considered highly bioavailable. Some labels may indicate whether the source is natural or synthetic, which can be important for those seeking a more natural product.
  5. Bioavailability: Some forms of Vitamin K, particularly MK-7, are more bioavailable than others, meaning they are more readily absorbed and utilized by the body. The label might indicate enhanced bioavailability or include information on absorption.
  6. Third-Party Testing and Certification: Look for supplements that have been tested by third-party organizations for purity, potency, and quality. Certifications from organizations such as NSF International, USP (United States Pharmacopeia), or ConsumerLab can provide assurance that the product meets high standards for quality and safety.
  7. Expiration Date: Always check the expiration date to ensure that the supplement is within its shelf life. The potency of vitamins can degrade over time, so using a product before its expiration date is crucial for maximum efficacy.
  8. Manufacturing Practices: Choose supplements from reputable brands that adhere to Good Manufacturing Practices (GMP). This information is often found on the label or the manufacturer's website and indicates that the product is produced in a facility that meets high standards for quality control.
  9. Allergen Information: If you have allergies or dietary restrictions, check the label for potential allergens such as gluten, dairy, soy, or nuts. Many supplements will specify if they are free from common allergens.
  10. Serving Size and Instructions: Ensure the label provides clear instructions on the serving size and how to take the supplement. This information can help you integrate the supplement into your daily routine effectively.

In summary, when evaluating a Vitamin K supplement, look for the specific type and dosage of Vitamin K, purity and absence of unnecessary additives, high bioavailability, third-party testing and certification, expiration date, adherence to GMP, and clear allergen information. By paying attention to these details, you can select a high-quality supplement that meets your health needs.

Back to table of contents


Disclaimer & References

The information provided on this website, including any text, images, or other material contained within, is for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. This page was created by the SuppCo editiorial team, with AI summarization tools, including data from but not limited to following studies:

  1. A. Mott, T. Bradley, Kath Wright, E. S. Cockayne, M. Shearer, J. Adamson, S. Lanham-New, D. Torgerson (2019). Effect of vitamin K on bone mineral density and fractures in adults: an updated systematic review and meta-analysis of randomised controlled trials. Osteoporosis International, , 1-17. Link: 10.1007/s00198-019-04949-0
  2. Liyou Hu, Jindou Ji, Dong Li, Jing Meng, Bo Yu (2021). The combined effect of vitamin K and calcium on bone mineral density in humans: a meta-analysis of randomized controlled trials. Journal of Orthopaedic Surgery and Research, 16, . Link: 10.1186/s13018-021-02728-4
  3. Salma Na, Syed Sufian Ahmad, S. Karim, I. Ibrahim, H. Alkreathy, M. Alsieni, M. Khan (2022). Effect of Vitamin K on Bone Mineral Density and Fracture Risk in Adults: Systematic Review and Meta-Analysis. Biomedicines, 10, . Link: 10.3390/biomedicines10051048
  4. S. Je, N. Joo, Beom-hee Choi, Kwang-Min Kim, Bom-Taeck Kim, S. Park, Doo-Yeoun Cho, Kyu-Nam Kim, D. Lee (2011). Vitamin K Supplement Along with Vitamin D and Calcium Reduced Serum Concentration of Undercarboxylated Osteocalcin While Increasing Bone Mineral Density in Korean Postmenopausal Women over Sixty-Years-Old. Journal of Korean Medical Science, 26, 1093 - 1098. Link: 10.3346/jkms.2011.26.8.1093
  5. Xiaotong Kuang, Chunxiao Liu, Xiaofei Guo, Kelei Li, Qingxue Deng, Duo Li (2020). The combination effect of vitamin K and vitamin D on human bone quality: a meta-analysis of randomized controlled trials.. Food & function, , . Link: 10.1039/c9fo03063h
  6. T. Ushiroyama, A. Ikeda, M. Ueki (2002). Effect of continuous combined therapy with vitamin K(2) and vitamin D(3) on bone mineral density and coagulofibrinolysis function in postmenopausal women.. Maturitas, 41 3,
    211-21 . Link: 10.1016/S0378-5122(01)00275-4
  7. Karin Levy-Schousboe, P. Marckmann, M. Frimodt-Møller, C. Peters, K. D. Kjærgaard, J. Jensen, C. Strandhave, H. Sandstrøm, M. Hitz, B. Langdahl, P. Vestergaard, C. Brasen, A. Schmedes, J. Madsen, N. Jørgensen, J. Frøkjær, N. E. Frandsen, I. Petersen, D. Hansen (2022). Vitamin K supplementation and bone mineral density in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial. Nephrology Dialysis Transplantation, 38, 2131 - 2142. Link: 10.1093/ndt/gfac315
  8. M. Shea, G. Dallal, B. Dawson-Hughes, J. Ordovás, C. O’Donnell, C. Gundberg, James W. Peterson, S. Booth (2008). Vitamin K, circulating cytokines, and bone mineral density in older men and women.. The American journal of clinical nutrition, 88 2,
    356-63 . Link: 10.1093/AJCN/88.2.356
  9. Yanfu Fang, Chuan-lai Hu, X. Tao, Y. Wan, F. Tao (2012). Effect of vitamin K on bone mineral density: a meta-analysis of randomized controlled trials. Journal of Bone and Mineral Metabolism, 30, 60-68. Link: 10.1007/s00774-011-0287-3
  10. Ming Ma, Ziyin Ma, Yilian He, Hao Sun, Bin Yang, Binjia Ruan, Wanhua Zhan, Shixiang Li, Hui Dong, Yong-xiang Wang (2022). Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials. Frontiers in Public Health, 10, . Link: 10.3389/fpubh.2022.979649
  11. K. Nimptsch, S. Rohrmann, R. Kaaks, J. Linseisen (2010). Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg).. The American journal of clinical nutrition, 91 5,
    1348-58 . Link: 10.3945/ajcn.2009.28691
  12. Kang-Tao Wang, Qianxue Wu, Zhuyue Li, Michael K Reger, Yongfu Xiong, G. Zhong, Qing Li, Xiang Zhang, Hong-Yuan Li, T. Foukakis, T. Xiang, Jianjun Zhang, G. Ren (2020). Vitamin K intake and breast cancer incidence and death: results from a prospective cohort study.. Clinical nutrition, , . Link: 10.1016/j.clnu.2020.11.009
  13. Claire R. Palmer, J. Bellinge, F. Dalgaard, M. Sim, Kevin Murray, E. Connolly, L. Blekkenhorst, C. Bondonno, K. Croft, G. Gislason, A. Tjønneland, K. Overvad, C. Schultz, J. Lewis, J. Hodgson, N. Bondonno (2021). Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort. European Journal of Epidemiology, 36, 1005 - 1014. Link: 10.1007/s10654-021-00806-9
  14. Sabine R. Zwakenberg, N. R. D. Braver, N. R. D. Braver, Anouk I. Engelen, E. Feskens, C. Vermeer, J. Boer, W. Verschuren, Y. T. V. D. Schouw, J. Beulens, J. Beulens (2017). Vitamin K intake and all-cause and cause specific mortality.. Clinical nutrition, 36 5,
    1294-1300 . Link: 10.1016/j.clnu.2016.08.017
  15. E. Roman, N. Fear, P. Ansell, D. Bull, G. Draper, P. McKinney, J. Michaelis, S. J. Passmore, R. von Kries (2002). Vitamin K and childhood cancer: analysis of individual patient data from six case–control studies. British Journal of Cancer, 86, 63 - 69. Link: 10.1038/sj.bjc.6600007
  16. Martí Juanola-Falgarona, J. Salas‐Salvadó, M. Martínez-González, D. Corella, R. Estruch, E. Ros, M. Fitó, F. Arós, E. Gómez-Gracia, M. Fiol, J. Lapetra, J. Basora, R. Lamuela-Raventós, L. Serra-Majem, X. Pintó, M. Muñoz, V. Ruíz-Gutiérrez, J. Fernandez-Ballart, M. Bulló (2014). Dietary intake of vitamin K is inversely associated with mortality risk.. The Journal of nutrition, 144 5,
    743-50 . Link: 10.3945/jn.113.187740
  17. Claire R. Palmer, J. Bellinge, F. Dalgaard, M. Sim, Kevin Murray, E. Connolly, L. Blekkenhorst, C. Bondonno, K. Croft, G. Gislason, A. Tjønneland, K. Overvad, C. Shultz, J. Lewis, J. Hodgson, N. Bondonno (2021). Dietary Intake of Vitamin K and Its Association With All-Cause, Cardiovascular Disease and Cancer Mortality in the Danish Diet, Cancer, and Health Cohort. Current Developments in Nutrition, , . Link: 10.1093/CDN/NZAB053_070
  18. Fang Yan, E. Eshak, A. Arafa, A. Tamakoshi, H. Iso (2022). Vitamin K Intake and Risk of Lung Cancer: The Japan Collaborative Cohort Study. Journal of Epidemiology, 33, 536 - 542. Link: 10.2188/jea.je20220063
  19. D. Ivanova, Z. Zhelev, P. Getsov, B. Nikolova, I. Aoki, T. Higashi, R. Bakalova (2018). Vitamin K: Redox-modulation, prevention of mitochondrial dysfunction and anticancer effect. Redox Biology, 16, 352 - 358. Link: 10.1016/j.redox.2018.03.013
  20. S. Booth, K. Tucker, Honglei Chen, M. Hannan, D. Gagnon, L. Cupples, P. Wilson, J. Ordovás, E. Schaefer, B. Dawson-Hughes, D. Kiel (2000). Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women.. The American journal of clinical nutrition, 71 5,
    1201-8 . Link: 10.1093/AJCN/71.5.1201
  21. Salma Na, Syed Sufian Ahmad, S. Karim, I. Ibrahim, H. Alkreathy, M. Alsieni, M. Khan (2022). Effect of Vitamin K on Bone Mineral Density and Fracture Risk in Adults: Systematic Review and Meta-Analysis. Biomedicines, 10, . Link: 10.3390/biomedicines10051048
  22. A. Mott, T. Bradley, Kath Wright, E. S. Cockayne, M. Shearer, J. Adamson, S. Lanham-New, D. Torgerson (2019). Effect of vitamin K on bone mineral density and fractures in adults: an updated systematic review and meta-analysis of randomised controlled trials. Osteoporosis International, , 1-17. Link: 10.1007/s00198-019-04949-0
  23. Wendy Fiordellisi, Katherine G. White, M. Schweizer (2018). A Systematic Review and Meta-analysis of the Association Between Vitamin K Antagonist Use and Fracture. Journal of General Internal Medicine, 34, 304-311. Link: 10.1007/s11606-018-4758-2
  24. N. Binkley, Judy M Harke, D. Krueger, J. Engelke, N. Vallarta‐Ast, D. Gemar, M. Checovich, R. Chappell, J. Suttie (2009). Vitamin K Treatment Reduces Undercarboxylated Osteocalcin but Does Not Alter Bone Turnover, Density, or Geometry in Healthy Postmenopausal North American Women. Journal of Bone and Mineral Research, 24, . Link: 10.1359/jbmr.081254
  25. Karin Levy-Schousboe, P. Marckmann, M. Frimodt-Møller, C. Peters, K. D. Kjærgaard, J. Jensen, C. Strandhave, H. Sandstrøm, M. Hitz, B. Langdahl, P. Vestergaard, C. Brasen, A. Schmedes, J. Madsen, N. Jørgensen, J. Frøkjær, N. E. Frandsen, I. Petersen, D. Hansen (2022). Vitamin K supplementation and bone mineral density in dialysis: results of the double-blind, randomized, placebo-controlled RenaKvit trial. Nephrology Dialysis Transplantation, 38, 2131 - 2142. Link: 10.1093/ndt/gfac315
  26. Mark Stevenson, M. Lloyd-Jones, D. Papaioannou (2009). Vitamin K to prevent fractures in older women: systematic review and economic evaluation.. Health technology assessment, 13 45,
    iii-xi, 1-134 . Link: 10.3310/hta13450
  27. Guangliang Hao, B. Zhang, Mingyong Gu, Chen Chen, Qiang Zhang, Guichun Zhang, Xuecheng Cao (2017). Vitamin K intake and the risk of fractures. Medicine, 96, . Link: 10.1097/MD.0000000000006725
  28. C. Gundberg (2009). Vitamin K and Bone: Past, Present, and Future. Journal of Bone and Mineral Research, 24, . Link: 10.1359/jbmr.090312
  29. A. Moore, Eunji Kim, D. Dulnoan, A. Dolan, K. Voong, Imtiaz Ahmad, R. Górska, D. Harrington, G. Hampson (2020). Serum vitamin K1 (phylloquinone) is associated with fracture risk and hip strength in post-menopausal osteoporosis: a cross-sectional study.. Bone, ,
    115630 . Link: 10.1016/j.bone.2020.115630
  30. M. C. Vera, F. Lorenzetti, Alvaro Lucci, C. G. Comanzo, M. P. Ceballos, G. Pisani, M. L. Álvarez, Ariel D. Quiroga, M. Carrillo (2019). Vitamin K2 supplementation blocks the beneficial effects of IFN-α-2b administered on the early stages of liver cancer development in rats.. Nutrition, 59,
    170-179 . Link: 10.1016/j.nut.2018.08.016
  31. D. Habu, S. Shiomi, A. Tamori, T. Takeda, Takashi Tanaka, S. Kubo, S. Nishiguchi (2004). Role of vitamin K2 in the development of hepatocellular carcinoma in women with viral cirrhosis of the liver.. JAMA, 292 3,
    358-61 . Link: 10.1001/JAMA.292.3.358
  32. Fang Yan, E. Eshak, A. Arafa, A. Tamakoshi, H. Iso (2022). Vitamin K Intake and Risk of Lung Cancer: The Japan Collaborative Cohort Study. Journal of Epidemiology, 33, 536 - 542. Link: 10.2188/jea.je20220063
  33. M. Kaneda, Dan Zhang, Rajib Bhattacharjee, K. Nakahama, S. Arii, I. Morita (2008). Vitamin K2 suppresses malignancy of HuH7 hepatoma cells via inhibition of connexin 43.. Cancer letters, 263 1,
    53-60 . Link: 10.1016/j.canlet.2007.12.019
  34. Jinghe Xia, T. Mizuta, I. Ozaki (2015). Vitamin K and hepatocellular carcinoma: The basic and clinic.. World journal of clinical cases, 3 9,
    757-64 . Link: 10.12998/wjcc.v3.i9.757
  35. S. Dahlberg, J. Ede, U. Schött (2017). Vitamin K and cancer. Scandinavian Journal of Clinical and Laboratory Investigation, 77, 555 - 567. Link: 10.1080/00365513.2017.1379090
  36. K. Nimptsch, S. Rohrmann, R. Kaaks, J. Linseisen (2010). Dietary vitamin K intake in relation to cancer incidence and mortality: results from the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg).. The American journal of clinical nutrition, 91 5,
    1348-58 . Link: 10.3945/ajcn.2009.28691
  37. A. Markowska, Michał Antoszczak, J. Markowska, Adam Huczyński (2022). Role of Vitamin K in Selected Malignant Neoplasms in Women. Nutrients, 14, . Link: 10.3390/nu14163401
  38. I. Riaz, Haris Riaz, Talha Riaz, Sophia Rahman, M. Amir, M. Badshah, Abdul Nafey Kazi (2012). Role of vitamin K2 in preventing the recurrence of hepatocellular carcinoma after curative treatment: A meta-analysis of randomized controlled trials. BMC Gastroenterology, 12, 170 - 170. Link: 10.1186/1471-230X-12-170
  39. H. Yoshida, Y. Shiratori, M. Kudo, S. Shiina, T. Mizuta, M. Kojiro, Kyosuke Yamamoto, Y. Koike, Kenichi Saito, N. Koyanagi, T. Kawabe, S. Kawazoe, H. Kobashi, H. Kasugai, Y. Osaki, Y. Araki, N. Izumi, H. Oka, K. Tsuji, J. Toyota, T. Seki, Toshiya Osawa, N. Masaki, M. Ichinose, M. Seike, A. Ishikawa, Y. Ueno, K. Tagawa, R. Kuromatsu, S. Sakisaka, H. Ikeda, Hidekatsu Kuroda, H. Kokuryu, T. Yamashita, I. Sakaida, T. Katamoto, K. Kikuchi, M. Nomoto, M. Omata (2011). Effect of vitamin K2 on the recurrence of hepatocellular carcinoma. Hepatology, 54, . Link: 10.1002/hep.24430

Back to table of contents

These statements have not been evaluated by the Food and Drug Administration. Any products and informational content displayed on this page are not intended to diagnose, treat, cure, or prevent any disease.